by Denise Purdie Andrews | Jun 6, 2023 | Drug Classes
By Stuart Kurtz, D-ABFT-FT In April, I spoke at the Midwest Association of Toxicology and Therapeutic Drug Monitoring (MATT) annual conference in Columbus, OH. The title of the talk was “Detection of Xylazine in Postmortem Specimens With Fentanyl, Morphine,...
by Denise Purdie Andrews | May 18, 2023 | Drug Classes
By Stuart Kurtz, M.S. D-ABFT-FT As discussed in the previous blog post, vitreous humor has many caveats when interpreting its results in the context of postmortem toxicology. For those considerations and some background on vitreous humor, check out that post first...
by Denise Purdie Andrews | May 5, 2023 | Drug Classes
By Stuart Kurtz, M.S. D-ABFT-FT The purpose of these next two blog posts is to discuss the utility that vitreous humor provides in the context of a case. This first post will focus on what vitreous humor is and the caveats associated with its interpretation. The...
by Denise Purdie Andrews | Apr 4, 2023 | Announcements
By Denise Purdie Andrews Recent industry news has been consumed with xylazine as the latest drug adulterant on the streets. Axis, your leading toxicology partner, has been testing for xylazine for several years and is prepared to assist you with questions about it...
by Denise Purdie Andrews | Mar 2, 2023 | Drug Classes
The purpose of this blog post is to take a look at some of our data regarding nitazene detections. For some background on nitazene compounds, take a look at our blog post of June 9, 2022 titled Drug Primer: Nitazenes. As a reminder, nitazenes are a structurally...
